News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientists identify key to preventing secondary cancers
Existing class of drugs for osteoporosis could stop the spread of the breast cancer to the bones, the most common site for the disease to spread.
World first as viral immunotherapy for skin cancer shows patient benefit in Phase III trial
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
Scientists unveil prostate cancer’s ‘Rosetta Stone’
Landmark study hails new era of personalised treatment for cancers that have spread round the body
Combining targeted cancer drugs is best when used to the max
Combining drugs that inhibit two signalling pathways critical to cancer growth could boost treatment outcomes for some types of cancer, but only when used together at maximum doses, a new study has found.
UK-US study compares radiotherapy with proton therapy in childhood cancer
The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, are leading a collaborative international study looking at the potential benefits of proton radiotherapy for young patients with brain tumours.
Scientists identify a new strategy to kill cancer cells
Scientists have discovered a new strategy to kill cancer cells with defects in genes responsible for DNA repair and cell division.
The ongoing battle with melanoma
Until recently there were no effective treatments for metastatic melanoma, but in the last decade we have seen a flurry of treatment breakthroughs, and scientists at the ICR have been at the heart of the fight against the disease.
Drug improves quality of life in men with advanced prostate cancer
The prostate cancer drug enzalutamide improves quality of life in men who haven’t previously received chemotherapy, a major Phase III clinical trial reports.
New drugs could stop skin cancer from spreading
Two new drugs could stop melanoma from spreading to other parts of the body, a new study has found.
ICR mourns leading molecular biologist Alan Hall, 1952–2015
Professor Alan Hall, a key figure in the development of molecular oncology at The Institute of Cancer Research, London, died suddenly in New York on 3 May.
Trial of new ‘resistance-busting’ skin cancer drug begins as first patient receives treatment
The patient has received a new panRAF inhibitor – a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
ICR's children's cancer researchers inspire donors and fundraisers
Members of the ICR’s Discovery Club and parents leading children’s cancer charities gathered in the inspiring surroundings of The Royal Society to hear about the ICR’s pioneering children’s cancer research.
